Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
INBX price, last 12 months
Key stats
- Previous close
- $69.06
- Open
- $70.19
- Day range
- $69.49 – $80.74
- 52-week range
- $57.30 – $155.29
- Volume
- 420.9K
- Avg volume (20 days)
- 324.8K
- Market cap
- $1.2B
Performance
Technicals and fundamentals
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $1.2B